Multi-laboratory validation of a standard method for quantifying proanthocyanidins in cranberry powders.

USDA-ARS, Arkansas Children's Nutrition Center, Little Rock, AR 72202, USA.
Journal of the Science of Food and Agriculture (Impact Factor: 1.88). 07/2010; 90(9):1473-8. DOI: 10.1002/jsfa.3966
Source: PubMed

ABSTRACT The objective of this study was to validate an improved 4-dimethylaminocinnamaldehyde (DMAC) colorimetric method using a commercially available standard (procyanidin A2), for the standard method for quantification of proanthocyanidins (PACs) in cranberry powders, in order to establish dosage guidelines for the uropathogenic bacterial anti-adhesion effect of cranberry.
Commercially available cranberry samples were obtained (five from U.S. sources and six from European sources) for PAC quantification in five different analytical laboratories. Each laboratory extracted and analyzed the samples using the improved DMAC method. Within-laboratory variation (mean +/- SD) was 4.1 +/- 1.7% RSD (range, 2.3-6.1% RSD) and the between laboratory variability was 16.9 +/- 8.5% RSD (range, 8-32% RSD). For comparative purposes, the cranberry samples were alternatively quantified using weights of extracted PACs (gravimetric). The correlation coefficient between the two methods was 0.989.
This improved DMAC method provides a simple, robust and relatively specific spectrophotometric assay for total PACs in cranberry samples using commercially available procyanidin A2 dimer as a standard. DMAC is most useful within a given type of food such as cranberries, but may not be appropriate for comparing concentrations across different food types, particularly in those cases where large differences exist among the relative amounts of each oligomer and polymer.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite the great marketing success, most physicians attribute poor efficacy to herbals. This perception is due to two situations that are an integral part of the herbal topic. The first is the poor phytochemical reproducibility obtained during the production process of herbal extracts, as herbal extracts are not always standardized in the whole manufacturing process, but only in their titer. The second problem is linked to the evolution of important enzymatic systems: cytochromes and ABC proteins. They are both enzyme classes with detoxifying properties and seem to have evolved from the molecular mould provided by active plant substances. During the evolution, as still happens today, polyphenols, saponins, terpenes, and alkaloids were ingested together with food. They do not possess any nutritional value but seem to be provided with a potential pharmacological activity. Cytochromes and ABC proteins, which evolved over time to detoxify food from vegetable chemical "actives," now seem to limit the action of herbal derivatives. The comprehension of these 2 events may explain the origin of the widespread scepticism of physicians about herbal medicine and suggests that, after correct herbal standardization, use of antagonists of cytochromes and ABC systems will make it possible to recover their pharmacological potential.
    TheScientificWorldJournal. 01/2014; 2014:732045.
  • [Show abstract] [Hide abstract]
    ABSTRACT: The CE marking is a statutory marking for certain products sold within the European Economic Area. Medicinal products with a CE label are not regulated by the European Medicines Agency but are licensed according to the directives of the European Community. We have analysed the proanthocyanin (PAC) content of four cranberry CE products by both a photometric (DMAC method using 4-dimethylamino-cinnamic-aldehyde as colouring reagent) and a high-performance liquid chromatography assay and have compared the daily dosages recommended for the products by their manufacturers with benchmark doses obtained from the literature. For all CE products, the identified DMAC values for the PAC content per unit were below those declared. For two of the CE medicinal products, not even the manufacturers' maximum daily dosages have type A PAC contents that would have any chance of providing the health benefits promised on the product information sheets; the other two might have some chance, but only at maximum dosage (nine capsules per day for one of them). CE medicinal products should be better controlled by regulatory authorities to prevent consumers from buying and taking doses that are inadequate to provide the benefits claimed. Copyright © 2014 John Wiley & Sons, Ltd.
    Phytotherapy Research 05/2014; · 2.40 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The chemical composition and in vitro antioxidant capacity (AC) of the two most commercialized species of jaboticaba, Sabará (Myrciaria jaboticaba) and Paulista (Myrciaria cauliflora), were compared in different fruit parts (skin, pulp and seeds) and at different ripening stages. Both species presented similar mineral and centesimal compositions, and were found to be rich sources of Mn (1.8–2.7 mg/100 g DW) and Cu (1.0 mg/100 g DW). Except for anthocyanins, phenolic concentrations were in greater amounts in Sabará than in Paulista. Ellagic acid derivatives (EA) contents varied according to ripening stage and also across fruit parts (skin, pulp and seeds). Unripe jaboticaba showed the highest contents of proanthocyanidins (PAC) and ellagitannins, as well as the greatest antioxidant capacity. Complete ripening led to a decrease of 47% in total EA, 43% in PAC, 60–77% in AC. Seeds displayed the highest concentrations of ellagitannins and proanthocyanidins and the greatest AC, whereas skin exhibited the highest amounts of anthocyanins and quercetin derivatives. Phenolics strongly inhibited carbohydrate-digesting enzymes. The unripe fruit showed the highest antioxidant capacity and phenolic contents, and ripening led to a decrease in all these compounds. Ready-to-consume fruits were shown to be very rich sources of polyphenols, especially anthocyanins, and an important source of ellagitannins, comparable to the berries.
    Food Research International 11/2013; 54(1):468–477. · 3.05 Impact Factor

Full-text (2 Sources)

Available from
Jun 2, 2014